drugset / Trial / NCT04377646
A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
Phase 3
Unknown
660 enrolled
Military Hospital of Tunis
Dacima Consulting · collabUR17DN02 : Autoimmune Diseases Research Unit · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
A multicenter randomized clinical trial aiming to assess the efficacy of hydroxychloroquine associated to Zinc compared to hydroxychloroquine, in the prevention of Military Health Professionals Exposed to SARS CoV2 in Tunisia
Timeline
- Start
- 2020-05-04
- Primary completion
- 2020-05-24
- Completion
- 2020-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydroxychloroquine | Small molecule | 400 mg | — |
| Comparator | Zinc Sulfate | Unknown | 15 mg | — |